Phase 2b Evaluation of Efficacy and Safety of AR882 in Gout Patients

Completed · Phase 2 · Has a placebo group

Conditions studied: Gout, Arthritis, Gouty, Hyperuricemia, Gout Chronic

In brief

This study will assess the serum uric acid lowering effect and safety of AR882 in gout patients at two doses compared to placebo over 12 weeks.

Key facts

Study ID

NCT05119686

Run by

Arthrosi Therapeutics

People needed

140

Starts

2021-11-16

Expected to finish

2022-11-17

Last updated by the study team

2023-05-12

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• History of gout
• sUA > 7 mg/dL
• Estimated Glomerular Filtration Rate (eGFR) ≥ 30 mL/min/1.73m2

You may not qualify if…

• Malignancy within 5 years, except for successfully treated basal or squamous cell carcinoma of the skin
• History of cardiac abnormalities
• History of kidney stones

Where it is running

• Arthrosi Investigative Site — Gilbert, Arizona, United States
• Arthrosi Investigative Site — Sun City, Arizona, United States
• Arthrosi Investigative Site — Tucson, Arizona, United States
• Arthrosi Investigative Site — Miami, Florida, United States
• Arthrosi Investigative Site — Miami Lakes, Florida, United States
• Arthrosi Investigative Site — Tampa, Florida, United States
• Arthrosi Investigative Site — Honolulu, Hawaii, United States
• Arthrosi Investigative Site — Overland Park, Kansas, United States
• Arthrosi Investigative Site — Cleveland, Ohio, United States
• Arthrosi Investigative Site — Cleveland, Ohio, United States
• Arthrosi Investigative Site — Duncansville, Pennsylvania, United States
• Arthrosi Investigative Site — Dallas, Texas, United States
• Arthrosi Investigative Site — Houston, Texas, United States
• Arthrosi Investigative Site — Tomball, Texas, United States
• Arthrosi Investigative Site — West Jordan, Utah, United States
• Arthrosi Investigative Site — Glendale, Wisconsin, United States
• Arthrosi Investigative Site — Melbourne, Camberwell, Australia
• Arthrosi investigative Site — Botany, New South Wales, Australia
• Arthrosi Investigative Site — Taichung, Taiwan
• Arthrosi Investigative Site - 301 — Taipei, Taiwan
• Arthrosi Investigative Site - 304 — Taipei, Taiwan
• Arthrosi Investigative Site — Taipei, Taiwan
• Arthrosi Investigative Site — Taoyuan, Taiwan

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.